Summary
A major goal of cancer therapy research is identification of critical biochemical targets that mediate the ability of effective cancer chemotherapy to kill tumor cells while allowing the maintenance of normal cell function. A candidate for such a target is DNA topoisomerase II, a ubiquitous enzyme that alters three-dimensional conformation of supercoiled DNA. DNA intercalating agents and epipodophyllotoxins stabilize a DNA and topoisomerase II complex. The process of stabilization probably represents the poisoning of an intermediate state in the normal functioning of the enzyme. This stabilized intermediate state can be measured in whole cells using the filter elution method of Kohn to quantify protein-associated DNA cleavage produced when the cells are exposed to intercalators or epipodophyllotoxins. By altering cell populations in quantifiable ways, four factors appear to influence the magnitude of drug-induced, topoisomerase II-mediated DNA cleavage and cytotoxicity: (a) the proliferative state of the cell (proliferating cells are more sensitive than quiescent ones); (b) the cell cycle state (cells pharmacologically recruited into G1-S are more sensitive than asynchronously growing cells); (c) the chromatin conformation (DNA methylation, polyamine depletion, and other chromosomal changes can alter the magnitude of topoisomerase II-mediated effects); (d) the cellular phenotype (in an as yet uncharacterized manner, malignant cells apparently are more sensitive to topoisomerase II-mediated events than normal cells). These data suggest that the biochemical basis of the therapeutic index of drugs such as the intercalating agents or epipodophyllotoxins may be the intrinsic hypersensitivity of the topoisomerase II in malignant cells to poisoning by these drugs.
Similar content being viewed by others
References
Nelson, EM, Tewey, KM, Liu, LF: Mechanism of antitumor drug action: Poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)methanesulfon-m-anisidide. Proc Natl Acad Sci USA 81: 1361–1365, 1984
Tewey, KM, Chen, GL, Nelson, EM, Liu, LF: Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259: 9182–9187, 1984
Tewey, KM, Rowe, TC, Yang, L, Halligan, BD, Liu, LF: Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466–468, 1984
Chen, GL, Yang, L, Rowe, TC, Halligan, BD, Tewey, KM, Liu, LF: Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259: 13560–13566, 1984
Bachur, NR, Gee, MY, Friedman, RD: Nuclear catalyzed antibiotic free radical formation. Cancer Res 42: 1078–1081, 1982
Bachur, NB, Gordon, SL, Gee, MY: A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38: 1745–1750, 1978
Bachur, NR, Gordon, SL, Gee, MY, Kon, K: NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 76: 954–957, 1979
Berlin, V, Haseltine, WA: Reduction of adriamycin to semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. J Biol Chem 256: 4747–4756, 1981
Ross, WE, Glaubiger, D, Kohn, KW: Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochim Biophys Acta 562: 41–50, 1979
Ross, WE, Glaubiger, DL, Kohn, KW: Protein-associated DNA breaks in cells treated with adriamycin or ellipticine. Biochim Biophys Acta 519: 23–30, 1978
Kohn, KW, Ewig, RAG, Erickson, LC, Zwelling, LA: Measurement of strand breaks and cross-links by alkaline elution. In: Friedberg, EC, Hanawalt, PC (eds): DNA repair: laboratory manual of research procedures. Marcel Dekker, New York, 1981, pp 379–401
Zwelling, LA, Michaels, S, Erickson, LC, Ungerleider, RS, Nichols, M, Kohn, KW: Protein-associated DNA strand breaks in L1210 cells treated with the DNA intercalating agents 4′-(9-acridinylamino)methanesulfon-m-anisidide and adriamycin. Biochemistry 20: 6553–6563, 1981
Zwelling, LA, Kerrigan, D, Michaels, S, Kohn, KW: Cooperative sequestration of m-AMSA in L1210 cells. Biochem Pharmacol 31: 3269–3277, 1982
Filipski, J, Kohn, KW: Ellipticine-induced protein-associated DNA breaks in isolated L1210 nuclei. Biochim Biophys Acta 698: 280–286, 1982
Pommier, Y, Kerrigan, D, Schwartz, R, Zwelling, LA: The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei. Biochem Biophys Res Commun 107: 576–583, 1982
Pommier, Y, Schwartz, RE, Kohn, KW, Zwelling, LA: Formation and rejoining of DNA double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents. Biochemistry 23: 3194–3201, 1984
Filipski, J, Yin, J, Kohn, KW: Reconstitution of intercalator-induced DNA scission by an active component from nuclear extracts. Biochim Biophys Acta 741: 116–122, 1983
Cook, PR, Brazell, IA: Supercoils in human DNA. J Cell Sci 19: 261–279, 1975
Mattern, MR, Painter, RB: Dependence of mammalian DNA replication on DNA supercoiling. I. Effects of ethidium bromide on DNA synthesis in permeable Chinese hamster ovary cells. Biochim Biophys Acta 563: 293–305, 1979
Mattern, MR, Zwelling, LA, Kerrigan, D, Kohn, KW: The reconstitution of higher-order DNA structure after x-irradiation of mammalian cells. Biochem Biophys Res Commun 112: 1077–1084, 1983
Pommier, Y, Mattern, MR, Schwartz, RE, Zwelling, LA, Kohn, KW: Changes in DNA linking number due to treatment of mammalian cells with the intercalating agent 4′-(9-acridinylamino)methanesulfon-m-anisidide. Biochemistry 23: 2927–2932, 1984
Gellert, M: DNA topoisomerases. Annual Review of Biochem 50: 879–910, 1981
Pommier, Y, Mattern, MR, Schwartz, RE, Zwelling, LA: Absence of swiveling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoids. Biochemistry 23: 2922–2927, 1984
Minford, JK, Kerrigan, D, Michaels, S, Kohn, KW, Pommier, Y, Mattern, M, Zwelling, LA: Intercalator-dependent DNA-protein crosslinking activity copurifies with a type II topoisomerase from murine leukemia cells. Proc Amer Association Cancer Res 25: 298, 1984
Higgins, NP, Cozzarelli, NR: The binding of gyrase to DNA: analysis by retention by nitrocellulose filters. Nucleic Acids Res 10: 6833–6847, 1982
Glisson, BS, Smallwood, SE, Ross, WE: Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells. Biochim Biophys Acta 783: 74–79, 1984
Long, BH, Brattain, MG: The activity of etoposide (VP-16–213) and Teniposide (VM-26) against human lung tumor cells in vitro: Cytotoxicity and DNA breakage. In: Issell, BF, Muggia, F, Carter, SK (eds): Etoposide (VP-16–213): current status and new developments. Academic Press, New York, 1984, pp 63–86
Ross, W, Rowe, T, Glisson, B, Yalowich, J, Liu, LF: Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res 44: 5857–5860, 1984
DiNardo, S, Voelkel, K, Sternglanz, R: DNA topoisomerase II mutant of Saccharomyces cerevisiare: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc Natl Acad Sci USA 81: 2616–2620, 1984
Duguet, M, Lavenot, C, Harper, F, Mirambeau, G, DeRecondo, AM: DNA topoisomerase from rat liver: physiological variations. Nucleic Acids Research 11: 1059–1075, 1983
Steck, TR, Drlica, K: Bacterial chromosome segregation: evidence for DNA gyrase involvement in decatenation. Cell 36: 1081–1088, 1984
Sundin, O, Varshavsky, A: Terminal stages of SV40 DNA replication proceed via multiply intertwined catenated dimers. Cell 21: 103–114, 1980
Sundin, O, Varshavsky, A: Arrest of segregation leads to accumulation of highly intertwined catenated dimers: dissection of the final stages of SV40 DNA replication. Cell 25: 659–669, 1981
Udvary, A, Schedl, P, Sander, M, Hsieh, T-S: Novel partitioning of DNA cleavage sites for Drosophila topoisomerase II. Cell 40: 933–941, 1985
Minford, J, Kerrigan, D, Nichols, M, Shackney, S, Zwelling, LA: Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-β-D-arabinofuranosyl-cytosine or hydroxuyrea in L1210 cells. Cancer Res 44: 5583–5593, 1984
Razin, A, Riggs, AD: DNA methylation and gene function. Science 210: 604–610, 1980
Christman, JK, Schneiderman, N, Acs, G: Formation of highly stable complexes between 5-azacytosine-substituted DNA and specific non-histone nuclear proteins. J Biol Chem 260: 4059–4068, 1985
Friedman, S: The inhibition of DNA (cytosine-5)methylases by 5-azacytidine. Mol Pharmacol 19: 314–320, 1981
Friedman, S: The irreversible binding of azacytosine-containing DNA fragments to bacterial DNA (cytosine-5) methyltransferases. J Biol Chem 260: 5698–5705, 1985
Kolata, G: Fitting methylation into development. Science 228: 1183–1184, 1985
Behe, M, Felsenfeld, G: Effects of methylation on a synthetic polynucleotide: the B-Z transition in poly(dG-m5dC)·poly(dG-m5dC). Proc Natl Acad Sci USA 78: 1619–1623, 1981
Nickol, J, Behe, M, Felsenfeld, G: Effect of the B-Z transition in poly (dG-m5dC)·poly(dG-m5dC) on nucleosome formation. Proc Natl Acad Sci USA 79: 1771–1775, 1982
Adams, RIP, Fulton, J, Kirk, D: The effect of 5-azadeoxycytidine on cell growth and DNA methylation. Biochim Biophys Acta 697: 286–294, 1982
Zwelling, LA, Minford, J, Nichols, M, Glazer, RL, Shackney, S: Enhancement of intercalator-induced DNA scission and cytotoxicity in murine leukemia cells treated with 5-azacytidine. Biochem Pharmacol 33: 3903–3906, 1984
Brown, PO, Cozzarelli, NR: Catenation and knotting of duplex DNA by type 1 topoisomerases: a mechanistic parallel with type 2 topoisomerases. Proc Natl Acad Sci USA 78: 843–847, 1981
Kreuzer, KN, Cozzarelli, NR: Formation and resolution of DNA catenanes by DNA gyrase. Cell 20: 245–254, 1980
Alhonen-Hongisto, L, Deen, DF, Marton, LJ: Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro. Cancer Res 44: 39–42, 1984
Alhonen-Hongisto, L, Deen, DF, Marton, LJ: Time dependence of the potentiation of 1,3-bis-(2-chloroethyl)-1-nitrosourea cytotoxicity caused by α-difluoromethylornithine-induced polyamine depletion in 9L rat brain tumor cells. Cancer Res 44: 1819–1822, 1984
Marton, LJ, Levin, VA, Hervatin, SJ, Koch-Weser, J, McCann, PP, Sjoerdsma, A: Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by α-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res 41: 4426–4431, 1981
Oredsson, SM, Deen, DF, Marton, LJ: Decreased cytotoxicity of cis-diamminedichloroplatinum (II) by α-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro. Cancer Res 42: 1296–1299, 1982
Oredsson, SM, Deen, DF, Marton, LJ: Influence of polyamine depletion caused by α-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on alkylation- and carbamoylation-induced cytotoxicity in 9L rat brain tumor cells in vitro. Cancer Res 43: 4606–4609, 1983
Oredsson, SM, Tofilon, PJ, Feuerstein, BG, Deen, DF, Rosenblum, ML, Marton, LJ: Differential potentiation of 1,3-bis(2-chloretyl)-1-nitrosourea by α-difluoromethylornithine in chloroethylnitrosourea-sensitive and-resistant 9L rat brain tumor cells in vivo. Cancer Res 43: 3576–3578, 1983
Sukara, PS, Fowler, SK, Nishioka, K, Rao, PN: Inhibition of polyamine biosynthesis by α-difluoromethylornithine potentiates the cytotoxic effects of arabinosylcytosine in HeLa cells. Biochem Biophys Res Commun 95: 423–430, 1980
Tofilon, PJ, Deen, DF, Marton, LJ: α-Difluoromethylornithine-induced polyamine depletion of 9L tumor cells modifies drug-induced DNA cross-link formation. Science 222: 1132–1135, 1983
Tofilon, PJ, Oredsson, SM, Deen, DF, Marton, LJ: Polyamine depletion influences drug-induced chromosomal damage. Science 217: 1044–1046, 1982
Zwelling, LA, Kerrigan, D, Marton, LJ: Effect of difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the topoisomerase II-mediated DNA scission produced by 4′-(9-acridinylamino)methanesulfon-m-anisidide in L1210 cells. Cancer Res 45: 1122–1126, 1985
Abeloff, MD, Slavik, M, Luk, GD, Griffin, CA, Herman, J, Blanc, O, Sjoerdsma, A, Baylin, SB: Phase I trial and pharmacokinetic studies of α-difluoromethylornithine — an inhibitor of polyamine biosynthesis. Journal of Clinical Oncology 2: 124–130, 1984
Zwelling, LA, Kerrigan, D, Lippman, ME: Protein-associated intercalator-induced DNA scission is enhanced by estrogen stimulation in human breast cancer cells. Proc Natl Acad Sci USA 80: 6182–6186, 1983
Hung, DT, Marton, LJ, Deen, DF, Shafer, RH: Depletion of intracellular polyamines may alter DNA conformation in 9L and rat brain tumor cells. Science 221: 368–370, 1983
Zwelling, LA, Mattern, MR: DNA-repair deficiences do not affect intercalator-induced cytotoxicity or DNA scission in human cells. Mutat Res 104: 295–304, 1982
Stein, GH: T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J Cell Physio 99: 43–54, 1979
Hittelman, WN: Prematurely condensed chromosomes: a model system for visualizing effects of DNA damage, repair and inhibition at the level of chromosome structure. In: Collins, A, Downes, S, Johnson, RT (eds). DNA repair and its inhibition: towards and analysis of mechanisms. IRL Press Limited, London, 1984, pp 341–371
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zwelling, L.A. DNA topoisomerase II as a target of antineoplastic drug therapy. Cancer Metast Rev 4, 263–276 (1985). https://doi.org/10.1007/BF00048092
Issue Date:
DOI: https://doi.org/10.1007/BF00048092